Choline bitartrate treatment of Alzheimer-type dementias

P. Fovall, M. W. Dysken, L. W. Lazarus, J. M. Davis, R. L. Kahn, Richard S Jope, S. Finkel, P. Rattan

Research output: Contribution to journalArticle

19 Citations (Scopus)

Abstract

We conducted a double-blind, placebo controlled study of the effects of choline bitartrate on intellectual performance in 5 patients with early Alzheimer-type dementia. Three doses of choline bitartrate (8 gm, 12 gm, and 16 gm) were given for two weeks each with a two-week placebo period either preceding (N=2) or following (N=3) the drug period. Cognitive testing was administered during a baseline period and thereafter once a week for the duration of the study. Comparing drug condition with placebo, we found significant improvement for auditory and visual word recognition at 12 gm per day of choline bitartrate. The mean plasma choline level nearly doubled from baseline to 12 gm per day. These results suggest improvement in some aspects of cognitive performance during choline bitartrate treatment.

Original languageEnglish (US)
Pages (from-to)141-145
Number of pages5
JournalCommunications In Psychopharmacology
Volume4
Issue number2
StatePublished - 1980
Externally publishedYes

Fingerprint

Choline
Alzheimer Disease
Placebos
Therapeutics
Pharmaceutical Preparations

ASJC Scopus subject areas

  • Medicine(all)

Cite this

Fovall, P., Dysken, M. W., Lazarus, L. W., Davis, J. M., Kahn, R. L., Jope, R. S., ... Rattan, P. (1980). Choline bitartrate treatment of Alzheimer-type dementias. Communications In Psychopharmacology, 4(2), 141-145.

Choline bitartrate treatment of Alzheimer-type dementias. / Fovall, P.; Dysken, M. W.; Lazarus, L. W.; Davis, J. M.; Kahn, R. L.; Jope, Richard S; Finkel, S.; Rattan, P.

In: Communications In Psychopharmacology, Vol. 4, No. 2, 1980, p. 141-145.

Research output: Contribution to journalArticle

Fovall, P, Dysken, MW, Lazarus, LW, Davis, JM, Kahn, RL, Jope, RS, Finkel, S & Rattan, P 1980, 'Choline bitartrate treatment of Alzheimer-type dementias', Communications In Psychopharmacology, vol. 4, no. 2, pp. 141-145.
Fovall P, Dysken MW, Lazarus LW, Davis JM, Kahn RL, Jope RS et al. Choline bitartrate treatment of Alzheimer-type dementias. Communications In Psychopharmacology. 1980;4(2):141-145.
Fovall, P. ; Dysken, M. W. ; Lazarus, L. W. ; Davis, J. M. ; Kahn, R. L. ; Jope, Richard S ; Finkel, S. ; Rattan, P. / Choline bitartrate treatment of Alzheimer-type dementias. In: Communications In Psychopharmacology. 1980 ; Vol. 4, No. 2. pp. 141-145.
@article{e1142e1d186d449fb0043030abda5aba,
title = "Choline bitartrate treatment of Alzheimer-type dementias",
abstract = "We conducted a double-blind, placebo controlled study of the effects of choline bitartrate on intellectual performance in 5 patients with early Alzheimer-type dementia. Three doses of choline bitartrate (8 gm, 12 gm, and 16 gm) were given for two weeks each with a two-week placebo period either preceding (N=2) or following (N=3) the drug period. Cognitive testing was administered during a baseline period and thereafter once a week for the duration of the study. Comparing drug condition with placebo, we found significant improvement for auditory and visual word recognition at 12 gm per day of choline bitartrate. The mean plasma choline level nearly doubled from baseline to 12 gm per day. These results suggest improvement in some aspects of cognitive performance during choline bitartrate treatment.",
author = "P. Fovall and Dysken, {M. W.} and Lazarus, {L. W.} and Davis, {J. M.} and Kahn, {R. L.} and Jope, {Richard S} and S. Finkel and P. Rattan",
year = "1980",
language = "English (US)",
volume = "4",
pages = "141--145",
journal = "Communications In Psychopharmacology",
issn = "0145-5699",
number = "2",

}

TY - JOUR

T1 - Choline bitartrate treatment of Alzheimer-type dementias

AU - Fovall, P.

AU - Dysken, M. W.

AU - Lazarus, L. W.

AU - Davis, J. M.

AU - Kahn, R. L.

AU - Jope, Richard S

AU - Finkel, S.

AU - Rattan, P.

PY - 1980

Y1 - 1980

N2 - We conducted a double-blind, placebo controlled study of the effects of choline bitartrate on intellectual performance in 5 patients with early Alzheimer-type dementia. Three doses of choline bitartrate (8 gm, 12 gm, and 16 gm) were given for two weeks each with a two-week placebo period either preceding (N=2) or following (N=3) the drug period. Cognitive testing was administered during a baseline period and thereafter once a week for the duration of the study. Comparing drug condition with placebo, we found significant improvement for auditory and visual word recognition at 12 gm per day of choline bitartrate. The mean plasma choline level nearly doubled from baseline to 12 gm per day. These results suggest improvement in some aspects of cognitive performance during choline bitartrate treatment.

AB - We conducted a double-blind, placebo controlled study of the effects of choline bitartrate on intellectual performance in 5 patients with early Alzheimer-type dementia. Three doses of choline bitartrate (8 gm, 12 gm, and 16 gm) were given for two weeks each with a two-week placebo period either preceding (N=2) or following (N=3) the drug period. Cognitive testing was administered during a baseline period and thereafter once a week for the duration of the study. Comparing drug condition with placebo, we found significant improvement for auditory and visual word recognition at 12 gm per day of choline bitartrate. The mean plasma choline level nearly doubled from baseline to 12 gm per day. These results suggest improvement in some aspects of cognitive performance during choline bitartrate treatment.

UR - http://www.scopus.com/inward/record.url?scp=0019121869&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=0019121869&partnerID=8YFLogxK

M3 - Article

C2 - 7428335

AN - SCOPUS:0019121869

VL - 4

SP - 141

EP - 145

JO - Communications In Psychopharmacology

JF - Communications In Psychopharmacology

SN - 0145-5699

IS - 2

ER -